Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Biomarker Assay for HCC Detection and Monitoring Piedmont Transplant Institute and Genetron Health, Inc.

NCT05494853 is registered in ClinicalTrials.gov with Genetron Health as lead sponsor.

NCT NCT05494853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05494853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Biomarker Assay for HCC Detection and Monitoring Piedmont Transplant Institute and Genetron Health, Inc.
Lead sponsor
Genetron Health
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2022
Completion date
December 1, 2025
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepato-cellular carcinoma